IP Library Assignment 049246/0785
Patent Assignment
Reel/Frame 049246/0785

Change of Assignee Address

Recorded: 2019-05-21 Pages: 5
Assignor
INDIVIOR UK LIMITED
Executed: 2019-05-21
Assignee
INDIVIOR UK LIMITED
THE CHAPLEO BUILDING HENRY BOOT WAY, PRIORY PARK, HULL, HU4 7DY, UNITED KINGDOM
Covered Properties (36)
Microbial N-and O-Demethylation of a Thebaine Derivative
Patent: 7,267,968 →
Application: 10/512,746 →
Publication: US 2005/0164358
Sustained Release Small Molecule Drug Formulation
Patent: 8,852,638 →
Application: 11/535,398 →
Publication: US 2007/0077304
Sustained Delivery Formulations of Risperidone Compounds
Application: 12/602,058 →
Publication: US 2010/0266655
Pack of Medicinal Tablets
Patent: 8,697,718 →
Application: 12/664,285 →
Publication: US 2010/0292265
Dehydrated Hydrogel Inclusion Complex of a Bioactive Agent with Flowable Drug Delivery System
Patent: 9,486,531 →
Application: 12/995,956 →
Publication: US 2011/0171305
Injectable Flowable Composition Comprising Buprenorphine
Patent: 8,921,387 →
Application: 13/703,013 →
Publication: US 2013/0210853
Compositions Comprising Buprenorphine
Patent: 9,295,645 →
Application: 13/703,015 →
Publication: US 2013/0202658
Sustained Release Small Molecule Drug Formulation
Patent: 9,044,450 →
Application: 13/790,930 →
Publication: US 2014/0086990
Injectable Flowable Composition Comprising Buprenorphine
Patent: 8,975,270 →
Application: 13/836,134 →
Publication: US 2013/0203796
Sustained Delivery Formulations of Risperidone Compounds
Patent: 9,180,197 →
Application: 14/490,034 →
Publication: US 2015/0099767
Sustained Delivery Formulations of Risperidone Compounds
Patent: 9,186,413 →
Application: 14/490,082 →
Publication: US 2015/0005323
Injectable Flowable Composition Buprenorphine
Patent: 9,272,044 →
Application: 14/610,818 →
Publication: US 2015/0216988
Sustained Release Small Molecule Drug Formulation
Patent: 9,597,402 →
Application: 14/701,173 →
Publication: US 2015/0231258
Sublingual and Buccal Film Compositions
Patent: 9,687,454 →
Application: 14/989,669 →
Publication: US 2016/0113885
Injectable Flowable Composition Comprising Buprenorphine
Patent: 9,498,432 →
Application: 14/995,053 →
Publication: US 2016/0128934
Compositions Comprising Buprenorphine
Application: 15/060,184 →
Publication: US 2016/0184296
Sustained-Release Buprenorphine Solutions
Application: 15/125,052 →
Publication: US 2017/0079974
Dehydrated Hydrogel Inclusion Complex
Application: 15/295,630 →
Publication: US 2017/0035895
Injectable Composition Comprising Buprenorphine
Patent: 9,782,402 →
Application: 15/334,000 →
Publication: US 2017/0079976
Sustained Release Small Molecule Drug Formulation
Application: 15/422,626 →
Publication: US 2017/0239252
Sublingual and Buccal Film Compositions
Application: 15/483,769 →
Publication: US 2017/0209431
Dopamine D3 Receptor Antagonist Compounds
Application: 15/522,863 →
Publication: US 2017/0334895
Buprenorphine Dosing Regimens
Application: 15/523,986 →
Publication: US 2017/0354653
Injectable Flowable Composition Comprising Buprenorphine
Patent: 9,827,241 →
Application: 15/623,191 →
Publication: US 2017/0281618
SUBSTITUTED HEXAHYDROPYRROLO[3,4-b]PYRROLES AND HEXAHYDROCYCLOPENTA[c]PYRROLES AS DOPAMINE RECEPTOR MODULATORS
Application: 15/750,128 →
Publication: US 2018/0222918
Injectable Flowable Composition Comprising Buprenorphine
Application: 15/820,048 →
Publication: US 2018/0157440
Sustained-Release Buprenorphine Formulations
Application: 15/847,548 →
Publication: US 2018/0243292
Injectable Flowable Composition Comprising Buprenorphine
Application: 15/857,507 →
Publication: US 2018/0121137
Sustained Delivery Formulations of Risperidone Compound
Application: 15/858,525 →
Publication: US 2018/0154001
Dopamine D3 Receptor Antagonists
Application: 15/975,466 →
Publication: US 2018/0282318
Sustained-Release Buprenorphine Solutions
Application: 16/016,186 →
Publication: US 2019/0022085
Methods to Treat Opioid Use Disorder
Application: 16/016,250 →
Publication: US 2018/0360821
Syringe System
Application: 16/041,170 →
Publication: US 2019/0380909
Sustained Release Small Molecule Drug Formulation
Application: 16/044,259 →
Publication: US 2018/0325905
Dopamine D3 Receptor Antagonist Compounds
Application: 16/261,206 →
Publication: US 2019/0300514
Substituted 3,6-Diazabicyclo[3.2.0]Heptanes
Application: 16/292,110 →
Publication: US 2019/0194225
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 31, 2012
From: RECKITT BENCKISER HEALTHCARE (UK) LIMITED
To: RB PHARMACEUTICALS LIMITED
Reel/Frame 028880/0277 →
Assignment of Assignor's Interest Sep 4, 2012
From: RECKITT BENCKISER HEALTHCARE (UK) LIMITED
To: RB PHARMACEUTICALS LIMITED
Reel/Frame 028893/0403 →
Assignment of Assignor's Interest Apr 21, 2014
From: NORTON, RICHARD L; WATKINS, ANDREW; ZHOU, MINGXING
To: RB PHARMACEUTICALS LIMITED
Reel/Frame 032716/0951 →
Release of Security Interest Aug 28, 2014
From: CREDIT SUISSE AG
To: ALCATEL LUCENT
Reel/Frame 033654/0968 →
Change of Name Sep 17, 2014
From: QLT USA, INC.
To: TOLMAR THERAPEUTICS, INC.
Reel/Frame 033763/0363 →
Assignment of Assignor's Interest Nov 24, 2014
From: TOLMAR THERAPEUTICS, INC.
To: RB PHARMACEUTICALS LIMITED
Reel/Frame 034254/0622 →
Assignment of Assignor's Interest Nov 24, 2014
From: DADEY, ERIC
To: QLT USA, INC.
Reel/Frame 034250/0151 →
Assignment of Assignor's Interest Dec 1, 2014
From: TOLMAR THERAPEUTICS, INC.
To: RB PHARMACEUTICALS LIMITED
Reel/Frame 034291/0200 →
Assignment of Assignor's Interest Dec 1, 2014
From: TOLMAR THERAPEUTICS, INC.
To: RB PHARMACEUTICALS LIMITED
Reel/Frame 034291/0096 →
Grant of Security Interest in Patents Dec 23, 2014
From: RB PHARMACEUTICALS LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC. AS COLLATERAL AGENT
Reel/Frame 034696/0885 →
Security Interest Mar 17, 2015
From: RB PHARMACEUTICALS LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 035186/0121 →
Assignment of Assignor's Interest Apr 29, 2015
From: DADEY, ERIC
To: QLT USA, INC.
Reel/Frame 035530/0266 →
Change of Name Apr 30, 2015
From: QLT USA, INC.
To: TOLMAR THERAPEUTICS, INC.
Reel/Frame 035554/0964 →
Assignment of Assignor's Interest May 8, 2015
From: NORTON, RICHARD L.; WATKINS, ANDREW; ZHOU, MINGXING
To: RB PHARMACEUTICALS LIMITED
Reel/Frame 035601/0154 →
Change of Name Aug 18, 2015
From: RB PHARMACEUTICALS LIMITED
To: INDIVIOR UK LIMITED
Reel/Frame 036388/0861 →
Change of Name Sep 21, 2015
From: RB PHARMACEUTICALS LIMITED
To: INDIVIOR UK LIMITED
Reel/Frame 036643/0841 →
Notice of Grant of Security Interest in Patents Dec 10, 2015
From: INDIVIOR UK LIMITED (FKA RB PHARMACEUTICALS LIMITED)
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 037268/0233 →
Assignment of Assignor's Interest Jan 29, 2016
From: INDIVIOR INC.
To: INDIVIOR UK LIMITED
Reel/Frame 037618/0977 →
Assignment of Assignor's Interest Jan 29, 2016
From: TOLMAR THERAPEUTICS INC.
To: INDIVIOR, INC.
Reel/Frame 037624/0933 →
Change of Name Feb 16, 2016
From: RB PHARMACEUTICALS LIMITED
To: INDIVIOR UK LIMITED
Reel/Frame 037837/0908 →
Change of Name Feb 17, 2016
From: RB PHARMACEUTICALS LIMITED
To: INDIVIOR UK LIMITED
Reel/Frame 037845/0778 →
Notice of Grant of Security Interest in Patents May 10, 2016
From: INDIVIOR UK LIMITED, FORMERLY RB PHAMACEUTICALS LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 038658/0700 →
Change of Name Sep 9, 2016
From: RB PHARMACEUTICALS LIMITED
To: INDIVIOR UK LIMITED
Reel/Frame 039981/0280 →
Assignment of Assignor's Interest Sep 9, 2016
From: MYERS, GARRY L.; HILBERT, SAMUEL D.; BOONE, BILL J.; BOGUE, B. ARLIE
To: MONOSOL RX, LLC
Reel/Frame 039690/0606 →
Assignment of Assignor's Interest Sep 9, 2016
From: MONOSOL RX, LLC
To: RECKITT BENCKISER HEALTHCARE (UK) LIMITED
Reel/Frame 039690/0551 →